Levetiracetamum [INN-Latin]
Brand names,
Levetiracetamum [INN-Latin]
Analogs
Levetiracetamum [INN-Latin]
Brand Names Mixture
Levetiracetamum [INN-Latin]
Chemical_Formula
C15H12I3NO4
Levetiracetamum [INN-Latin]
RX_link
http://www.rxlist.com/cgi/generic3/liothyronine.htm
Levetiracetamum [INN-Latin]
fda sheet
Levetiracetamum [INN-Latin]
msds (material safety sheet)
Levetiracetamum [INN-Latin]
Synthesis Reference
No information avaliable
Levetiracetamum [INN-Latin]
Molecular Weight
650.974 g/mol
Levetiracetamum [INN-Latin]
Melting Point
236.5 oC
Levetiracetamum [INN-Latin]
H2O Solubility
3.96 mg/L
Levetiracetamum [INN-Latin]
State
Solid
Levetiracetamum [INN-Latin]
LogP
3.001
Levetiracetamum [INN-Latin]
Dosage Forms
Tablet
Levetiracetamum [INN-Latin]
Indication
Used as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyrodism during the recovery phase of subacute thyroiditis.
Levetiracetamum [INN-Latin]
Pharmacology
Thyroid hormone drugs are natural or synthetic preparations containing tetraiodothyronine (T4, levothyroxine) or triiodothyronine (T3, liothyronine) or both. T4 and T3 are produced in the human thyroid gland by the iodination and coupling of the amino acid tyrosine. Liothyronine (T3) contains three atoms of iodine and is formed by the coupling of one molecule of diiodotyrosine (DIT) with one molecule of monoiodotyrosine (MIT). These hormones enhance oxygen consumption by most tissues of the body and increase the basal metabolic rate and the metabolism of carbohydrates, lipids and proteins. Thus, they exert a profound influence on every organ system in the body and are of particular importance in the development of the central nervous system.
Levetiracetamum [INN-Latin]
Absorption
Almost totally absorbed, 95 percent in 4 hours.
Levetiracetamum [INN-Latin]
side effects and Toxicity
No information avaliable
Levetiracetamum [INN-Latin]
Patient Information
Levetiracetamum [INN-Latin]
Organisms Affected
Humans and other mammals